Rights and permissions
About this article
Cite this article
Deferoxamine remains the mainstay of iron chelation therapy. Inpharma Wkly. 765, 9–10 (1990). https://doi.org/10.2165/00128413-199007650-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199007650-00023